Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 3 pseudogene 3 (TBC1D3P3), also known as USP6P1 (ubiquitin specific peptidase 6 pseudogene 1), is classified as a pseudogene in the human genome. A pseudogene is a segment of DNA that is similar to a gene but does not encode a functional protein product, typically due to mutations or deletions that disrupt normal gene expression. TBC1D3P3 does not produce an active protein and is not considered a functional molecular target, enzyme, transporter, or receptor. It has no well-established roles in normal physiology, disease pathways, or current therapeutic relevance. There are currently no drugs or biomarkers associated with TBC1D3P3, and no safety concerns or therapeutic challenges have been linked to it.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 3 pseudogene 3 (TBC1D3P3).